Literature DB >> 15309007

Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease.

Monvadi B Srichai1, Paulo R Schvartzman, Bernhard Sturm, Jane M Kasper, Michael L Lieber, Richard D White.   

Abstract

BACKGROUND: Hyper-enhancement on delayed-enhancement magnetic resonance imaging (DE-MRI) is a marker of irreversible myocardial injury. Both reversible and irreversible ischemically injured regions of myocardium develop reductions in systolic function compared with unaffected regions. This study evaluated whether there is a relationship between myocardial hyper-enhancement from remote scarring on DE-MRI and the degree of myocardial circumferential shortening (%CS) as determined with dynamic MRI tissue tagging (TAG-MRI) in the setting of chronic ischemic heart disease (CIHD).
METHODS: Thirty-five patients with CIHD and 8 control patients underwent nonstress, resting DE-MRI and TAG-MRI. A total of 168 CIHD and 96 control segments from the basal- and middle-thirds of the left ventricle (LV) were selected to achieve a balanced test set. With a 16-segment model, segmental myocardial scarring was graded on the basis of the amount of hyper-enhancement on DE-MRI. With TAG-MRI images, segmental %CS was calculated.
RESULTS: Patients with CIHD had lower LV ejection fraction compared with the control patients (28% vs 67%). The %CS of normal segments was notably different from %CS of CIHD segments, regardless of the presence or absence of myocardial hyper-enhancement on DE-MRI. Among the CIHD segments, however, %CS correlated inversely with the amount of myocardial hyper-enhancement from scarring (P <.0001, r = -0.38).
CONCLUSIONS: On cardiac MRI for CIHD, myocardial hyper-enhancement correlates inversely with %CS, supporting the direct relationship between the amount of remote myocardial scarring determined with nonstress DE-MRI and baseline resting functional impairment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15309007     DOI: 10.1016/j.ahj.2004.03.007

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Myocardial delayed enhancement in pulmonary hypertension: pulmonary hemodynamics, right ventricular function, and remodeling.

Authors:  Monda L Shehata; Dirk Lossnitzer; Jan Skrok; Danielle Boyce; Noah Lechtzin; Stephen C Mathai; Reda E Girgis; Nael Osman; Joao A C Lima; David A Bluemke; Paul M Hassoun; Jens Vogel-Claussen
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

2.  Free-breathing combined three-dimensional phase sensitive late gadolinium enhancement and T1 mapping for myocardial tissue characterization.

Authors:  Sebastian Weingärtner; Mehmet Akçakaya; Sébastien Roujol; Tamer Basha; Cory Tschabrunn; Sophie Berg; Elad Anter; Reza Nezafat
Journal:  Magn Reson Med       Date:  2014-10-16       Impact factor: 4.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.